NCT06104878 - A Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy Alone | Biotech Hunter

Timeline

Start Date

December 31, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions

Hodgkin Lymphoma

Interventions

OTHER

No Intervention

No Intervention will be administered in this study.

Trial Locations (6)

Hospital São Rafael - Instituto D'Or de Pesquisa e Ensino, Salvador

Instituto D'Or de Pesquisa e Ensino, Brasília

Oncoclinicas Rio de Janeiro S.A, Rio de Janeiro

Beneficência Portuguesa de São Paulo - Real Benemerita Associação Portuguesa de Beneficência, São Paulo

Hospital Alemão Oswaldo Cruz - HAOC, São Paulo

AC Camargo Cancer Center / Fundação Antonio Prudente Liberdade, São Paulo